Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Mehrnaz Ajorloo

Mehrnaz Ajorloo

Avicenna Research center, Iran

Title: New approaches to cervical cancer treatment by reformed sperms

Biography

Biography: Mehrnaz Ajorloo

Abstract

Cervical cancer is a type of cancer that started from the cervix of rheum and it spreads to other parts of the textures of the target or other organs. Across the world, this type of cancer is the fourth leading cause of death in women, According to the global statistics out of every 528000, 266000 deaths have been reported that occurs mostly in developing countries. Chemotherapy and radiotherapy are commonly used in this cancer, as you know, chemotherapy-based treatments will have very serious side effects for the body and may cause serious damage to healthy cells close to the tumor during the removal of cancer cells.

According to researches and expert studies on effective methods for the delivery of therapeutic drugs to tumors and adequate knowledge of the structure and function of sperms, recently, we have come to the conclusion that these mobile cells can be used to deliver medications to the tumor site. This method has many advantages, including the packaging of the drug for treating cervical cancer that this makes it so do not dilute medications in body fluids and do not leak out and also the desired medication keep away from existing enzymes and they do not stimulate the immune response. Another advantage of this treatment method is that Sperms are inherently motile and could transmit them exactly to the place of the tumors by magnetic panels that added to these drug carriers until according to their normal function release the drug into tumors in the cervix that this causes to the drug reach to deeper cancer cells in the masses. This therapeutic mechanism has been a very low risk and currently, it is under experimentally discussion and research.